BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1760904)

  • 1. Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features.
    Taylor PM; O'Driscoll BR; Gattamaneni HR; Woodcock AA
    Clin Radiol; 1991 Nov; 44(5):299-301. PubMed ID: 1760904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.
    O'Driscoll BR; Hasleton PS; Taylor PM; Poulter LW; Gattameneni HR; Woodcock AA
    N Engl J Med; 1990 Aug; 323(6):378-82. PubMed ID: 2370889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation.
    Parish JM; Muhm JR; Leslie KO
    Mayo Clin Proc; 2003 May; 78(5):630-4. PubMed ID: 12744552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma.
    Hasleton PS; O'Driscoll BR; Lynch P; Webster A; Kalra SJ; Gattamaneini HR; Woodcock AA; Poulter LW
    J Pathol; 1991 May; 164(1):31-6. PubMed ID: 2056387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced fatal pulmonary fibrosis.
    Somló P; Révész T
    Neoplasma; 1984; 31(6):739-44. PubMed ID: 6521801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary fibrosis following low-dose 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) therapy.
    Melato M; Tuveri G
    Cancer; 1980 Mar; 45(6):1311-4. PubMed ID: 7357522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive pulmonary fibrosis during combination chemotherapy with BCNU (author's transl)].
    Schreml W; Bargon G; Anger B; Kubanek B; Heimpel H
    Blut; 1978 Jun; 36(6):353-6. PubMed ID: 656638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy.
    Richter JE; Hastedt R; Dalton JF; Marshall D; Raymond LW
    Cancer; 1979 May; 43(5):1607-12. PubMed ID: 445356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary toxicity from carmustine (BCNU): a case report.
    Weiss RB; Shah S; Shane SR
    Med Pediatr Oncol; 1979; 6(3):255-9. PubMed ID: 470840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary fibrosis: a complication of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
    Ryan BR; Walters TR
    Cancer; 1981 Aug; 48(4):909-11. PubMed ID: 7272934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis.
    Selker RG; Jacobs SA; Moore PB; Wald M; Fisher ER; Cohen M; Bellot P
    Neurosurgery; 1980 Dec; 7(6):560-5. PubMed ID: 7207751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Sweet DL
    Ann Intern Med; 1979 Jul; 91(1):132-3. PubMed ID: 464443
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Stillerman R
    Ann Intern Med; 1979 Jul; 91(1):132. PubMed ID: 464442
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Weiss RB; Muggia FM
    Ann Intern Med; 1979 Jul; 91(1):131-2. PubMed ID: 464441
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Kaplan RL
    Ann Intern Med; 1979 Jul; 91(1):131. PubMed ID: 464440
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary fibrosis after prolonged therapy with 1,3-bis (2-chloroethyl)-1-nitrosourea.
    Crittenden D; Tranum BL; Haut A
    Chest; 1977 Sep; 72(3):372-3. PubMed ID: 891293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
    Bailey CC; Marsden HB; Jones PH
    Cancer; 1978 Jul; 42(1):74-6. PubMed ID: 667809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrent bilateral pneumothorax in progressive lung fibrosis following combination therapy with BCNU].
    Vetter N; Berger E; Otupal I; Jürgenssen OA
    Prax Klin Pneumol; 1985 Mar; 39(3):102-5. PubMed ID: 3991454
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-beta1 and cyclooxygenase-2.
    Shen YC; Chiu CF; Chow KC; Chen CL; Liaw YC; Yeh SP
    Bone Marrow Transplant; 2004 Oct; 34(7):609-14. PubMed ID: 15286697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible pulmonary toxicity after single course of BCNU.
    Lieberman A; Ruoff M; Estey E; Seidman I; Lieberman I; Wise A
    Am J Med Sci; 1980; 279(1):53-6. PubMed ID: 7369249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.